Orthocell Limited (ASX:OCC – Get Free Report) insider John Wielen acquired 35,000 shares of the firm’s stock in a transaction dated Monday, April 15th. The stock was bought at an average price of A$0.39 ($0.25) per share, with a total value of A$13,650.00 ($8,806.45).
Orthocell Stock Performance
The company has a current ratio of 4.60, a quick ratio of 5.07 and a debt-to-equity ratio of 34.88.
About Orthocell
Read More
- Five stocks we like better than Orthocell
- How to Invest in Biotech Stocks
- Comprehensive Analysis of PayPal Stock
- What is the Nikkei 225 index?
- Intuitive Surgical Stock Can Trend Much Higher This Year
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Orthocell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthocell and related companies with MarketBeat.com's FREE daily email newsletter.